Stockscreener 앱 받기
5.35
1.90%
0.10
시장 영업 전:
5.11
-0.24
-4.49%
Edesa Biotech Inc 주식(EDSA)의 최신 뉴스
Edesa Biotech Inc (EDSA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Edesa Biotech Inc (EDSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Edesa Biotech Inc (EDSA) Income Statement - TradingKey
Edesa Biotech Market Sentiment - Benzinga España
Edesa Biotech Inc (EDSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
EDSA|Edesa Biotech Inc|Price:5.250|Chg%:-0.410 - TradingKey
Why Did EDSA Stock Rally More Than 70% Today? - Stocktwits
TradingKey - TradingKey
Edesa Biotech, Inc. Revenue Breakdown – NASDAQ:EDSA - TradingView
Edesa Biotech Inc (EDSA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech? - Stocktwits
Edesa Biotech (EDSA) Revenue BreakdownMain Composition - Moomoo
EDSA Stock Soars More Than 700% So Far This Year: Wall Street Eyes Further Upside In Run Up To Acute Kidney Injury Data Reveal - Stocktwits
Edesa Biotech, Inc. SEC Filing (Jul 14, 2026) - Stock Titan
Edesa Biotech (EDSA) Declines 2.85% as Shares Approach Key Support ZoneGamma Flip Level - dars.gov.et
Edesa Biotech (EDSA) details $3.5M private placement and 729,241-share resale - Stock Titan
Edesa Biotech | 424B3: Prospectus - Moomoo
Enterprise value to EBIT forward of Edesa Biotech, Inc. – NASDAQ:EDSA - TradingView
Edesa Biotech Company Profile & Introduction - Moomoo
Edesa Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Nijhawan Pardeep - Moomoo
EDSA Should I Buy - Intellectia AI
Form S-3 EDESA BIOTECH For: 2 July By Investing.com - Investing.com Nigeria
Edesa Biotech (EDSA) CEO receives 3,378-share RSU grant - Stock Titan
Edesa Biotech (NASDAQ: EDSA) registers 729,241 shares for resale - Stock Titan
EDSA: Positive Exploratory Data in Patients with AKI - Yahoo Finance
Edesa Biotech Inc. (EDSA) Q1 2026 Earnings: Wider-Than-Expected Loss Weighs on SharesShare Repurchase Impact - dars.gov.et
Brookline Capital Initiates Edesa Biotech(EDSA.US) With Buy Rating, Announces Target Price $21 - Moomoo
Brookline initiates Edesa Biotech stock with buy on pipeline By Investing.com - Investing.com Nigeria
Brookline initiates Edesa Biotech stock with buy on pipeline - Investing.com
Edesa Biotech Inc. (EDSA) Q1 2026 Earnings: Wider-than-expected loss as pre-revenue biotech continues R&D spendingMargin Guidance - dars.gov.et
Edesa Biotech Inc (EDSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Edesa Biotech, Inc. Actuals & Estimates (NASDAQ:EDSA) - TradingView
Price to book forward of Edesa Biotech, Inc. – NASDAQ:EDSA - TradingView
EDSA Forecast — Price Target — Prediction for 2027 - TradingView
Edesa Biotech Inc (EDSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Edesa Biotech Inc (EDSA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Edesa Biotech Inc. (EDSA) Q1 2026 Earnings: EPS Misses Estimates as Company Continues Pipeline DevelopmentGuidance Revision Trend - dars.gov.et
CEO, Company Secretary & Director of Edesa Biotech Pardeep Nijhawan Buys 28% More Shares - simplywall.st
EDSA Q1 2026 Earnings: EPS Misses Estimates, Stock Gains Despite Wider LossGuidance vs Actual - dars.gov.et
Edesa Biotech (EDSA) joint filing reports 5.4% stake by Millennium group - Stock Titan
Edesa Biotech announces $3.5M PIPE financing - MSN
Edesa Biotech Inc (EDSA) Institutional Confidence - TradingKey
Edesa Biotech Inc (EDSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Edesa Biotech (EDSA) Surges 9.73%: Breaking Above Key Support LevelsDemand Zone - DonanımHaber
1.97%
0.83%
자본화:
|
볼륨(24시간):